Mounjaro®
Starting from £179.99/mo
Start journey Learn moreYes, you can inject Wegovy incorrectly, and some mistakes matter more than others. Injecting into the wrong tissue layer, reusing a needle, or choosing a site that isn't licensed for subcutaneous injections can all reduce how reliably the medicine is absorbed or increase your chance of a local reaction. Wegovy is a prescription-only semaglutide injection, meaning every dose should be given exactly as your prescriber and the Patient Information Leaflet direct. Most mistakes are avoidable once you know what to look for — and none of them should make you afraid to start.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The majority of injection errors begin before the needle ever touches skin. Wegovy pens are stored in the fridge (2–8°C), and using one that is still fully chilled can cause unnecessary discomfort and sometimes affects how smoothly the medicine delivers. Many people keep their current pen in the fridge door rather than the back shelf, where temperatures stay more stable. Allow the pen to sit at room temperature for a short period before use, and confirm the exact timing in your Patient Information Leaflet, the SmPC specifies the allowable window, and that document is always the governing source.
Check the pen before using it. The medicine should be clear and colourless or very faintly yellow; never inject a pen if the liquid is cloudy, discoloured, or contains visible particles. Confirm the expiry date. Remove the pen cap only when you are ready to inject. The NHS semaglutide guidance is a useful plain-English reference for these pre-use checks alongside your leaflet.
If you are nervous about injecting for the first time, that is entirely normal, most patients say the anticipation is considerably worse than the injection itself. Slowing down for the preparation steps helps.
Wegovy should be injected into subcutaneous fat tissue in one of three approved areas: the abdomen (at least a few centimetres from the navel), the front of the thigh, or the outer upper arm. Anywhere outside these three sites is outside the licensed guidance. Injecting too deeply into muscle rather than the fat layer beneath the skin changes the absorption profile and can cause more soreness. The pen's needle is sized for subcutaneous injection at these sites, using it correctly means pressing the pen flat against a slightly pinched section of skin.
Rotating the site each week matters. Injecting repeatedly into exactly the same small patch of skin builds up fatty deposits (lipohypertrophy), which the NHS England weight-management injections guidance identifies as a known risk of poor rotation practice. A simple rule: same region is fine, same centimetre-square spot is not.
If you are curious about less conventional site choices, there is specific guidance on whether the buttocks are an appropriate injection site, the short answer is no, it is not a licensed site for Wegovy.
One of the most common technique errors is withdrawing the pen too quickly. The pen should stay pressed against the skin until the dose window confirms the injection is complete, removing it early can mean only a partial dose is delivered. Keep the pen still and let the mechanism finish.
Air bubbles visible through the viewing window before injection can make patients anxious. Small air bubbles in a pre-filled pen are normal and do not need to be expelled; the pen is not a syringe and should not be primed in the same way. If you have genuine doubts about whether a dose was delivered fully, do not take an extra dose, contact your prescriber or pharmacist first. Our support team is available seven days a week if you are unsure.
On what happens if a dose goes wrong in practice, there is more detail on what to do if you think you injected Wegovy incorrectly, including when to call a clinician and when to simply continue your usual schedule.
After each injection, replace the outer cap and dispose of the used pen safely. Wegovy pens contain a needle and should never go in household recycling or an ordinary bin. A puncture-resistant sharps container is the correct disposal route; your pharmacy or GP surgery can advise on local collection. Reusing a pen from a previous week is never appropriate, even if it appeared to have medicine remaining.
Storing spare pens correctly matters too. Freezing permanently damages the medicine, a pen that has been frozen should not be used. If you are unsure whether the temperature went below zero, err on the side of caution and contact your prescriber. More on the cold-chain question is covered in the guide to injecting Wegovy cold. For broader context on how semaglutide injections work as a category, the guidance on semaglutide injection technique more generally covers the shared principles. And if you are still at the stage of working out where to source genuine, clinically supervised treatment, the Wegovy sourcing guide explains what a legitimate supply chain looks like.
If you are ready to have your eligibility assessed or want to ask a prescriber about injection technique directly, you can start a free consultation, a real clinician reads every submission the same day.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.